Effect of vasodilator hydralazine on tumor microvascular random flow and blood volume as measured by intravoxel incoherent motion (IVIM) weighted MRI in conjunction with Gd-DTPA-Albumin enhanced MRI

Magnetic Resonance Imaging

Volumn 19, Issue 8, 2001, Pages 1063-1072

  Wang, Zhiheng ^a   Su, Min Ying ^a   Najafi, A ^a   Nalcioglu, Orhan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blood volume fraction; Gd DTPA Albumin; Hydralazine; IVIM weighted MRI; Microvascular random flow; Vasodilator

Indexed keywords

ALBUMIN; GADOLINIUM PENTETATE ALBUMIN; HYDRALAZINE; ALBUMIN (GADOLINIUM DTPA); ALBUMIN-(GADOLINIUM-DTPA); ALBUMINOID; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE; VASODILATOR AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFACT REDUCTION; BLOOD FLOW VELOCITY; BLOOD VOLUME; BREAST TUMOR; COMPARTMENT MODEL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG EFFECT; FEMALE; INTRAVOXEL INCOHERENT MOTION WEIGHTED MAGNETIC RESONANCE IMAGING; MEASUREMENT; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SIGNAL PROCESSING; TIME SERIES ANALYSIS; TUMOR BLOOD FLOW; TUMOR VOLUME; VASODILATATION; ADENOCARCINOMA; ANIMAL; EXPERIMENTAL NEOPLASM; FISCHER 344 RAT; METHODOLOGY; MICROCIRCULATION; PATHOPHYSIOLOGY; VASCULARIZATION;

ADENOCARCINOMA; ALBUMINS; ANIMALS; BLOOD FLOW VELOCITY; BLOOD VOLUME; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HYDRALAZINE; MAGNETIC RESONANCE IMAGING; MAMMARY NEOPLASMS, EXPERIMENTAL; MICROCIRCULATION; MODELS, ANIMAL; RATS; RATS, INBRED F344; VASODILATOR AGENTS;

EID: 0035489158     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0730-725X(01)00431-3     Document Type: Article

References (37)

1. Jain RK, Weissbro, JM, Wei J. Mass transport in tumors: characterization and applications to chemotherapy. Advances in Cancer Research 1980;33:251-310.
2. Horsman MR, Chaplin DJ, Overgaard J. The use of blood flow modifiers to improve the treatment response of solid tumors. Radiother Oncol 1991;20:47-52.
3. Chaplin DJ, Acker BD, Horsman MR. Reduction of tumour blood flow by vasoactive drugs: a role in cancer therapy. BioMed Biochim Acta 1989;48:S264-68.
4. Voorhees WD, Babba CF. Hydralazine-enhanced selective heating of transmissible venereal tumor implants in dogs. Eur J Cancer Clin Oncol 1982;18:1027-33.
5. Horsman MR, Christensen KL, Overgaard J. Relationship between the hydralazine-induced changes in murine tumor blood supply and mouse blood pressure. Int J Radiat Oncol Biol Phys 1992;22:455-8.
6. Kozin SV, Hasegawa T, Ha-Kawa SK, Akagi K, Tanaka Y. Hydralazine at thermoradiotherapy: tumor size and blood flow effects. Int J Radiat Oncol Biol Phys 1994;29:505-10.
7. Honess DJ, Bleehen NM. Comparative effects of hydralazine on perfusion of KHT tumor, kidney and liver and on renal function in mice. Int J Radiat Oncol Biol Phys 1992;22:953-61.
8. Belfi CA, Ting LL, Hassenbusch SJ, Tefft M, Ngo FQ. Determination of changes in tumor blood perfusion after hydralazine treatment by dynamic paramagnetic-enhanced magnetic resonance imaging. Int J Radiat Oncol Biol Phys 1992;22:477-82.
9. Belfi CA, Paul CR, Shan S, Ngo FQ. Comparison of the effects of hydralazine on tumor and normal tissue blood perfusion by MRI. Int J Radiat Oncol Biol Phys 1994;29:473-9.
10. Peters CE, Chaplin DJ. Blood flow modification in the SCCVII tumor: effects of 5-hydroxytryptamine, hydralazine, and propranolol. Int J Radiat Oncol Biol Phys 1992;22:463-5.
11. Zlotecki RA, Baxter LT, Boucher Y, Jain RK. Pharmacologic modification of tumor blood flow and interstitial fluid pressure in a human tumor xenograft: network analysis and mechanistic interpretation. Microvas Res 1995;50:429-43.
12. Yamamoto M, Kusumoto T, Endo K, Baba H, Sakaguchi Y, Maehara Y, Sugimachi K. Vasoacting agents flavone acetic acid and hydralazine given in combination enhance antitumor effects under condition of hyperthermia. Oncology 1996;53:147-52.
13. Kalmus J, Okunieff P, Vaupel P. Dose-dependent effects of hydralazine on microcirculatory function and hyperthermic response of murine FSall tumors. Cancer Res 1990;50:15-9.
14. Tyml K, Ellis CG. Simultaneous assessment of red cell perfusion in skeletal muscle by laser Doppler flowmetry and video microscopy. Int J Microcirc Clin Exp 1985;4:397-406.
15. Shepherd AP, Riedel GL, Kiel JW, Haumschild DJ, Maxwell LC. Evaluation of an infrared laser-Doppler blood flowmeter. Am J Physiol 1987;252:G832-9.
16. Nalcioglu O, Cho ZH, Xiang QS, Ahn CB. Incoherent flow imaging. Proc SPIE 1986;671:285-9.
17. Nalcioglu O, Cho ZH, Measurement of bulk and random directional velocity fields by NMR imaging. IEEE Trans Med Imaging 1987;MI-6:356-9.
18. Xiang QS, Nalcioglu O, Measurement of mean and variance of velocity fields within each voxel by NMR imaging. IEEE Trans Med Imaging 1988;MI-7:364-7.
19. Ahn CB, Lee SY, Nalcioglu O, Cho ZH, The effects of random directional distributed flow in nuclear magnetic resonance imaging. Med Phys 1987;14:43-8.
20. Su MY, Nalcioglu O. Statistical description of microvascular flow as measured with an MR method. J Magn Reson Imaging 1993;3:883-7.
21. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988;168:497-505.
22. Chenevert TL, Pipe JG, Williams DM, Brunberg JA. Quantitative measurement of tissue perfusion and diffusion in vivo. Magn Reson Med 1991;17:197-212.
23. Maki JH, MacFall JR, Johnson GA. The use of gradient flow compensation to separate diffusion and microvascular flow in MRI. Magn Reson Med 1991;17:95-107.
24. King MD, van Bruggen N, Busza AL, Houseman J, Williams SR, Gadian DG. Perfusion and diffusion MR imaging. Magn Reson Med 1992;24:288-301.
25. Fujita N, Harada K, Sakurai K, Akai Y, Kozuka T. Separation of diffusion and slow flow effects by use of flow rephasing and dephasing. Magn Reson Med 1992;24:109-22.
26. Neil JJ, Bosch CS, Ackerman JJ. An evaluation of the sensitivity of the intravoxel incoherent motion (IVIM) method of blood flow measurement to changes in cerebral blood flow. Magn Reson Med 1994;32:60-5.
27. Rosen BR, Belliveau JW, Chien D. Perfusion imaging by nuclear magnetic resonance. Magn Reson Quarterly 1989;5:263-81.
28. Wang Z, Su MY, Nalcioglu O. Measurement of tumor blood volume and mean microvascular random flow velocity magnitude by dynamic Gd-DTPA-Albumin enhanced and diffusion weighted MRI. Magn Reson Med 1998;40:397-404.
29. Kuwatsuru R, Shames DM, Muhler A, Mintorovitch J, Vexler V, Mann JS, Cohn F, Price D, Huberty J, Brasch RC. Quantification of tissue plasma volume in the rat by contrast-enhanced magnetic resonance imaging. Magn Reson Med 1993;30:76-81.
30. Su MY, Najafi AA, Nalcioglu O. Regional comparison of tumor vascularity and permeability parameters measured by albumin-Gd-DTPA and Gd-DTPA. Magn Reson Med 1995;34:402-11.
31. Schwickert HC, Roberts TP, Shames DM, van Dijke CF, Disston A, Muhler A, Mann JS, Brasch RC. Quantification of liver blood volume: comparison of ultra short TI inversion recovery echo planar imaging (ULSTIR-EPI), with dynamic 3D-gradient recalled echo imaging. Magn Reson Med 1995;34:845-52.
32. Demsar F, Roberts TP, Schwickert H, Shames DM, van Dijke CF, Mann JS, Saeed M, Brasch RC. A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution. Magn Reson Med 1997;37:236-42.
33. Su MY, Wang Z, Roth GM, Lao X, Samoszuk MK, Nalcioglu O. Pharmacokinetic changes induced by vasomodulators in kidneys, livers, muscles, and implanted tumors in rats as measured by dynamic Gd-DTPA-enhanced MRI. Magn Reson Med 1996;36:868-77.
34. Abramovitch R, Frenkiel D, Neeman M, Analysis of subcutaneous angiogenesis by gradient echo magnetic resonance imaging. Magn Reson Med 1998;39:813-24.
35. Foltz WD, Merchant N, Downar E, Stainsby JA, Wright GA. Coronary venous oximetry using MRI. Magn Reson Med 1999;42:837-48.
36. Barth M, Moser E. Proton NMR relaxation times of human blood samples at 1.5 T and implications for functional MRI. Cellular and Molecular Biology 1997;43:783-91.
37. Fullerton GD, Potter JL, Dornbluth NC. NMR relaxation of protons in tissues and other macromolecular water solutions. Magn Reson Imaging 1982;1:209-26.